NCT00982579View on ClinicalTrials.gov

Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

September 30, 2011

Conditions
HIV-1HIV Infections
Interventions
BIOLOGICAL

MVA.HIVA

1 dose of 5 x 10\^7 pfu of MVA.HIVA administered intramuscularly

Trial Locations (1)

Unknown

Medical Research Council Laboratories, The Gambia, Banjul

Sponsors
All Listed Sponsors
collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

lead

Medical Research Council

OTHER_GOV